Ravina Bernard 4
4 · Voyager Therapeutics, Inc. · Filed Nov 13, 2017
Insider Transaction Report
Form 4
Ravina Bernard
Chief Medical Officer
Transactions
- Sale
Common Stock
2017-11-10$13.26/sh−5,490$72,797→ 16,473 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.50, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.